186(top 100%)
PR articles
61.3K(top 0.1%)
PR citations
98(top 100%)
PR h-index
110(top 100%)
h-index
210
documents
84.4K
doc citations
5.3K
citing journals
100
times ranked

Publications

187 PR articles • 64,754 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1indelPost: harmonizing ambiguities in simple and complex indel alignments
Bioinformatics, 2022, 38, 549-551
4.817Citations (PDF)
2A <i>CTNNB1</i>‐altered medulloblastoma shows the immunophenotypic, DNA methylation and transcriptomic profiles of SHH‐activated, and not WNT‐activated, medulloblastoma3.23Citations (PDF)
3Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
Hepatology, 2022, 76, 1634-1648
10.624Citations (PDF)
4RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data
Leukemia, 2022, 36, 1492-1498
10.440Citations (PDF)
5Infectious Diseases/Human Immunodeficiency Virus Physician Ambassadors: Advancing Policy to Improve Health
Clinical Infectious Diseases, 2021, 73, e2243-e2250
5.43Citations (PDF)
6The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study4.728Citations (PDF)
7The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis
Laryngoscope, 2021, 131, 610-617
1.525Citations (PDF)
8Multiomic analysis identifies natural intrapatient temporal variability and changes in response to systemic corticosteroid therapy in chronic rhinosinusitis2.67Citations (PDF)
9Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
Cancer Cell, 2021, 39, 38-53.e7
38.594Citations (PDF)
10DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association4.441Citations (PDF)
11Responses of <i>Chlamydomonas reinhardtii</i> during the transition from P‐deficient to P‐sufficient growth (the P‐overplus response): The roles of the vacuolar transport chaperones and polyphosphate synthesis
Journal of Phycology, 2021, 57, 988-1003
3.038Citations (PDF)
12Conservation genomics of a critically endangered brown seaweed
Journal of Phycology, 2021, 57, 1345-1355
3.07Citations (PDF)
13Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity4.212Citations (PDF)
14A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma4.210Citations (PDF)
15Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing
Cancer Discovery, 2021, 11, 3008-3027
25.6177Citations (PDF)
16Differences in Breast and Colorectal Cancer Screening Adherence Among Women Residing in Urban and Rural Communities in the United States
JAMA Network Open, 2021, 4, e2128000
6.867Citations (PDF)
17ID/HIV Physician Ambassadors: Advancing Policy to Improve Health1.53Citations (PDF)
18Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival13.975Citations (PDF)
19Identification of novel fusion transcripts in meningioma
Journal of Neuro-Oncology, 2020, 149, 219-230
2.610Citations (PDF)
20Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples13.944Citations (PDF)
21Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression
Cancer Research, 2020, 80, 3810-3819
0.626Citations (PDF)
22Proteogenomic Characterization of Endometrial Carcinoma
Cell, 2020, 180, 729-748.e26
34.1425Citations (PDF)
23Pathway and network analysis of more than 2500 whole cancer genomes13.999Citations (PDF)
24The repertoire of mutational signatures in human cancer
Nature, 2020, 578, 94-101
38.73,137Citations (PDF)
25Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Nature, 2020, 578, 102-111
38.7570Citations (PDF)
26Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
Cancer Research, 2020, 80, 2663-2675
0.686Citations (PDF)
27An enhanced genetic model of colorectal cancer progression history
Genome Biology, 2019, 20,
8.243Citations (PDF)
28Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas
Cell Reports, 2019, 28, 1370-1384.e5
6.4552Citations (PDF)
29Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Cell Reports, 2019, 29, 1675-1689.e9
6.4148Citations (PDF)
30Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
Cell, 2019, 179, 964-983.e31
34.1635Citations (PDF)
31Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors7.6179Citations (PDF)
32Framework for microRNA variant annotation and prioritization using human population and disease datasets
Human Mutation, 2019, 40, 73-89
3.922Citations (PDF)
33How Do You Measure Up: Quality Measurement for Improving Patient Care and Establishing the Value of Infectious Diseases Specialists
Clinical Infectious Diseases, 2019, 68, 1946-1951
5.46Citations (PDF)
34Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Cancer Discovery, 2018, 8, 730-749
25.6459Citations (PDF)
35Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer
Cell, 2018, 173, 864-878.e29
34.1136Citations (PDF)
36An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Cell, 2018, 173, 400-416.e11
34.13,192Citations (PDF)
37Comprehensive Characterization of Cancer Driver Genes and Mutations
Cell, 2018, 173, 371-385.e18
34.12,053Citations (PDF)
38Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Cell, 2018, 173, 291-304.e6
34.12,264Citations (PDF)
39Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics
Cell, 2018, 173, 305-320.e10
34.1359Citations (PDF)
40Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Cell, 2018, 173, 338-354.e15
34.11,951Citations (PDF)
41Oncogenic Signaling Pathways in The Cancer Genome Atlas
Cell, 2018, 173, 321-337.e10
34.12,852Citations (PDF)
42Pathogenic Germline Variants in 10,389 Adult Cancers
Cell, 2018, 173, 355-370.e14
34.1782Citations (PDF)
43Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Cell Reports, 2018, 23, 282-296.e4
6.4423Citations (PDF)
44Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Cell Reports, 2018, 23, 227-238.e3
6.4567Citations (PDF)
45The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Cell Reports, 2018, 23, 313-326.e5
6.4679Citations (PDF)
46Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
Cell Reports, 2018, 23, 181-193.e7
6.4907Citations (PDF)
47The Immune Landscape of Cancer
Immunity, 2018, 48, 812-830.e14
23.34,904Citations (PDF)
48Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Cell Reports, 2018, 23, 172-180.e3
6.4145Citations (PDF)
49Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Cell Reports, 2018, 23, 239-254.e6
6.41,025Citations (PDF)
50Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Cell Reports, 2018, 23, 270-281.e3
6.4222Citations (PDF)
51Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines
Cell Systems, 2018, 6, 271-281.e7
5.8789Citations (PDF)
52Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Cancer Cell, 2018, 33, 676-689.e3
38.51,015Citations (PDF)
53A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
Cancer Cell, 2018, 33, 690-705.e9
38.5605Citations (PDF)
54Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway
Gastroenterology, 2018, 154, 195-210
1.0127Citations (PDF)
55A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily
Cell Systems, 2018, 7, 422-437.e7
5.8171Citations (PDF)
56TBIO-20. CLINICAL TUMOR WHOLE EXOME SEQUENCING FOR PEDIATRIC NEURO-ONCOLOGY PATIENTS – RESULTS FROM THE BAYLOR ADVANCING SEQUENCING IN CHILDHOOD CANCER CARE (BASIC3) CLINICAL SEQUENCING STUDY
Neuro-Oncology, 2018, 20, i184-i184
1.10Citations (PDF)
57Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer
Journal of Thoracic Oncology, 2018, 13, 1483-1495
2.228Citations (PDF)
58Integrated Molecular Characterization of Testicular Germ Cell Tumors
Cell Reports, 2018, 23, 3392-3406
6.4420Citations (PDF)
59SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers13.9100Citations (PDF)
60Genomic Alterations of Adamantinomatous and Papillary Craniopharyngioma1.858Citations (PDF)
61Whole-genome landscape of pancreatic neuroendocrine tumours
Nature, 2017, 543, 65-71
38.7913Citations (PDF)
62Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Cell, 2017, 169, 1327-1341.e23
34.12,193Citations (PDF)
63Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma
European Urology, 2017, 72, 641-649
2.2203Citations (PDF)
64Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports, 2017, 18, 2780-2794
6.4502Citations (PDF)
65A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
Nature Genetics, 2017, 49, 1487-1494
26.1339Citations (PDF)
66Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Cancer Cell, 2017, 32, 185-203.e13
38.51,824Citations (PDF)
67Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Hepatology, 2017, 65, 104-121
10.6234Citations (PDF)
68SVachra: a tool to identify genomic structural variation in mate pair sequencing data containing inward and outward facing reads
BMC Genomics, 2017, 18,
3.38Citations (PDF)
69Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions
Oncotarget, 2017, 8, 11114-11126
1.723Citations (PDF)
70Activating <i>MAPK1</i> (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma
Oncotarget, 2017, 8, 46065-46070
1.733Citations (PDF)
71Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs1.33Citations (PDF)
72Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates13.9146Citations (PDF)
73Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera
Blood, 2016, 128, 2266-2270
4.225Citations (PDF)
74Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes
Experimental Hematology, 2016, 44, 740-744
0.457Citations (PDF)
75Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Cancer Cell, 2016, 29, 723-736
38.5580Citations (PDF)
76Significance of <i>TP53</i> Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group
Clinical Cancer Research, 2016, 22, 5582-5591
6.999Citations (PDF)
77Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle1.527Citations (PDF)
78MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data
Genome Biology, 2016, 17,
8.2281Citations (PDF)
79An open access pilot freely sharing cancer genomic data from participants in Texas
Scientific Data, 2016, 3,
5.723Citations (PDF)
80Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
Cell Reports, 2016, 14, 2476-2489
6.4338Citations (PDF)
81Acquired uniparental disomy of chromosome 9p in hematologic malignancies
Experimental Hematology, 2016, 44, 644-652
0.414Citations (PDF)
82ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data
BMC Bioinformatics, 2016, 17,
3.018Citations (PDF)
83Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
JAMA Oncology, 2016, 2, 616
14.6447Citations (PDF)
84Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair
Cell, 2016, 164, 538-549
34.1423Citations (PDF)
85Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
Cell Reports, 2016, 14, 907-919
6.4127Citations (PDF)
86Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch
Molecular Therapy, 2016, 24, 736-745
10.415Citations (PDF)
87Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer2.234Citations (PDF)
88Genomic analyses identify molecular subtypes of pancreatic cancer
Nature, 2016, 531, 47-52
38.73,324Citations (PDF)
89Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse
Cancer Research, 2016, 76, 2197-2205
0.6153Citations (PDF)
90Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma43.71,229Citations (PDF)
91Destabilized SMC5/6 complex leads to chromosome breakage syndrome with severe lung disease
Journal of Clinical Investigation, 2016, 126, 2881-2892
10.782Citations (PDF)
92Integrated Genomic Analysis of Down Syndrome Acute Lymphoblastic Leukemia Reveals Recurrent Cancer Gene Alterations and Evidence of Frequent Subclonal Driver Events
Blood, 2016, 128, 4083-4083
4.20Citations (PDF)
93Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: <i>PALB2</i> mutation predicts exceptional <i>in vivo</i> response to BMN 6731.473Citations (PDF)
94A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing13.9288Citations (PDF)
95MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours13.985Citations (PDF)
96Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors
Cancer Cell, 2015, 27, 286-297
38.5288Citations (PDF)
97Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia13.9317Citations (PDF)
98Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation
Blood, 2015, 125, 629-638
4.2225Citations (PDF)
99Assessing structural variation in a personal genome—towards a human reference diploid genome
BMC Genomics, 2015, 16,
3.3160Citations (PDF)
100Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney13.9150Citations (PDF)
101Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Nature Genetics, 2015, 47, 1426-1434
26.1311Citations (PDF)
102Comparison of Positive End-Expiratory Pressure of 8 versus 5 cm H<sub>2</sub>O on Outcome After Cardiac Operations2.38Citations (PDF)
103SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization
Genome Biology, 2014, 15,
8.264Citations (PDF)
104Mutational Landscape of Aggressive Cutaneous Squamous Cell Carcinoma
Clinical Cancer Research, 2014, 20, 6582-6592
6.9568Citations (PDF)
105Heterochromatin protein 1 expression is reduced in human thyroid malignancy
Laboratory Investigation, 2014, 94, 788-795
3.39Citations (PDF)
106Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Cell, 2014, 159, 676-690
34.12,761Citations (PDF)
107Effects of <i><scp>TP53</scp></i> mutational status on gene expression patterns across 10 human cancer types
Journal of Pathology, 2014, 232, 522-533
5.075Citations (PDF)
108Genomic Sequencing for Cancer Diagnosis and Therapy
Annual Review of Medicine, 2014, 65, 33-48
19.539Citations (PDF)
109Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Nature Genetics, 2014, 46, 1267-1273
26.1732Citations (PDF)
110Characterization of HPV and host genome interactions in primary head and neck cancers7.6369Citations (PDF)
111Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types13.9531Citations (PDF)
112Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication
Genome Research, 2014, 24, 1740-1750
4.6276Citations (PDF)
113The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Cancer Cell, 2014, 26, 319-330
38.5771Citations (PDF)
114Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers
Clinical Cancer Research, 2014, 20, 3842-3848
6.9136Citations (PDF)
115Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
Blood, 2014, 124, 3007-3015
4.2404Citations (PDF)
116BCOR–CCNB3 fusions are frequent in undifferentiated sarcomas of male children
Modern Pathology, 2014, 28, 575-586
4.9139Citations (PDF)
117Genomic Characterization of Sinonasal Undifferentiated Carcinoma1.11Citations (PDF)
118Mixed Phenotype Acute Leukemia (MPAL) Has a High Frequency of Mutations in Epigenetic Regulatory Genes: Results from Whole Exome Sequencing
Blood, 2014, 124, 3560-3560
4.24Citations (PDF)
119Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif13.9114Citations (PDF)
120<i>MLH1</i>‐silenced and non‐silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes
Journal of Pathology, 2013, 229, 99-110
5.069Citations (PDF)
121Combined sequence-based and genetic mapping analysis of complex traits in outbred rats
Nature Genetics, 2013, 45, 767-775
26.1185Citations (PDF)
122From human genome to cancer genome: The first decade
Genome Research, 2013, 23, 1054-1062
4.6152Citations (PDF)
123Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers
Cancer Discovery, 2013, 3, 770-781
25.6530Citations (PDF)
124Comparison Of Mutational Profiles Of Diagnosis and Relapsed Pediatric B-Acute Lymphoblastic Leukemia: A Report From The COG ALL Target Project
Blood, 2013, 122, 824-824
4.25Citations (PDF)
125Whole Exome Sequencing and Analysis Of Mutations In Sézary Syndrome
Blood, 2013, 122, 2558-2558
4.20Citations (PDF)
126Molecular Characterization Of Polycythemia Vera Based On The Relationship Of JAK2V617F and 9pUPD
Blood, 2013, 122, 1607-1607
4.20Citations (PDF)
127Dietary Determinants Of The White Blood Cell Count
Blood, 2013, 122, 1705-1705
4.20Citations (PDF)
128Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Nature, 2012, 491, 399-405
38.71,915Citations (PDF)
129Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma
PLoS ONE, 2012, 7, e34546
2.4113Citations (PDF)
130Identification of Novel Somatic Mutations, Regions of Recurrent Loss of Heterozygosity (LOH) and Significant Clonal Evolution From Diagnosis to Relapse in Childhood AML Determined by Exome Capture Sequencing – an NCI/COG Target AML Study
Blood, 2012, 120, 123-123
4.23Citations (PDF)
131Genome Wide Promoter Methylation Patterns Predict AML Subtype Outcomes and Identify Novel Pathways Characterizing Diagnostic and Relapsed Disease in Children
Blood, 2012, 120, 1287-1287
4.23Citations (PDF)
132Whole Genome Sequencing of Four CD34+-Derived iPSC Polycythemia Vera Clones From a Single Female
Blood, 2012, 120, 1755-1755
4.22Citations (PDF)
133Whole Exome Sequencing of Polycythemia Vera Reveals Novel Recurrent Somatic and Germline Variation
Blood, 2012, 120, 705-705
4.23Citations (PDF)
134Clinically Significant Mutations, Deletions and Translocations Involving ETV6 Identified by Whole Genome and Whole Exome Sequencing; Report From NCI/COG Target AML Initiative
Blood, 2012, 120, 125-125
4.20Citations (PDF)
135Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase
Cell, 2011, 144, 703-718
34.1265Citations (PDF)
136Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy
Cell, 2011, 145, 1036-1048
34.1288Citations (PDF)
137Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel
Cancer Genetics, 2011, 204, 19-25
0.614Citations (PDF)
138Resequencing of<i>IRS2</i>reveals rare variants for obesity but not fasting glucose homeostasis in Hispanic children
Physiological Genomics, 2011, 43, 1029-1037
2.56Citations (PDF)
139TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum
Nature Genetics, 2011, 43, 189-196
26.1344Citations (PDF)
140A Primer on a Hepatocellular Carcinoma Bioresource Bank Using the Cancer Genome Atlas Guidelines: Practical Issues and Pitfalls
World Journal of Surgery, 2011, 35, 1732-1737
2.84Citations (PDF)
141Building a Comprehensive Genomic Program for Hepatocellular Carcinoma
World Journal of Surgery, 2011, 35, 1746-1750
2.815Citations (PDF)
142Overview of the Development of Personalized Genomic Medicine and Surgery
World Journal of Surgery, 2011, 35, 1693-1699
2.820Citations (PDF)
143Characterization of single-nucleotide variation in Indian-origin rhesus macaques (Macaca mulatta)
BMC Genomics, 2011, 12,
3.331Citations (PDF)
144Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed
Human Mutation, 2011, 32, 661-668
3.9207Citations (PDF)
145Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion7.6216Citations (PDF)
146Disruptive <i>TP53</i> Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer
Clinical Cancer Research, 2011, 17, 6658-6670
6.9103Citations (PDF)
147Integrating common and rare genetic variation in diverse human populations
Nature, 2010, 467, 52-58
38.72,916Citations (PDF)
148A SNP discovery method to assess variant allele probability from next-generation resequencing data
Genome Research, 2010, 20, 273-280
4.6170Citations (PDF)
149Deep resequencing reveals excess rare recent variants consistent with explosive population growth13.9218Citations (PDF)
150Whole-Genome Sequencing in a Patient with Charcot–Marie–Tooth Neuropathy
New England Journal of Medicine, 2010, 362, 1181-1191
43.7724Citations (PDF)
151Genome-Wide Analysis of Binding Sites and Direct Target Genes of the Orphan Nuclear Receptor NR2F1/COUP-TFI
PLoS ONE, 2010, 5, e8910
2.444Citations (PDF)
152Common and rare variants of <i>DAOA</i> in bipolar disorder1.512Citations (PDF)
153Mutations in Smooth Muscle Alpha-Actin (ACTA2) Cause Coronary Artery Disease, Stroke, and Moyamoya Disease, Along with Thoracic Aortic Disease6.5545Citations (PDF)
154Somatic mutations affect key pathways in lung adenocarcinoma
Nature, 2008, 455, 1069-1075
38.72,781Citations (PDF)
155Novel MicroRNA Candidates and miRNA-mRNA Pairs in Embryonic Stem (ES) Cells
PLoS ONE, 2008, 3, e2548
2.448Citations (PDF)
156Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome
Genome Research, 2007, 17, 760-774
4.6187Citations (PDF)
157Direct selection of human genomic loci by microarray hybridization
Nature Methods, 2007, 4, 903-905
25.9639Citations (PDF)
158Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
Nature, 2007, 447, 799-816
38.74,877Citations (PDF)
159A second generation human haplotype map of over 3.1 million SNPs
Nature, 2007, 449, 851-861
38.74,275Citations (PDF)
160Functional genomics of genes with small open reading frames (sORFs) in S. cerevisiae
Genome Research, 2006, 16, 365-373
4.6218Citations (PDF)
161The DNA sequence of the human X chromosome
Nature, 2005, 434, 325-337
38.71,058Citations (PDF)
162SNPdetector: A Software Tool for Sensitive and Accurate SNP Detection3.1110Citations (PDF)
163Orphan Nuclear Receptor GCNF Is Required for the Repression of Pluripotency Genes during Retinoic Acid-Induced Embryonic Stem Cell Differentiation
Molecular and Cellular Biology, 2005, 25, 8507-8519
2.5174Citations (PDF)
164Comparative genome sequencing of Drosophila pseudoobscura: Chromosomal, gene, and cis-element evolution
Genome Research, 2005, 15, 1-18
4.6473Citations (PDF)
165Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of Embryonic Development
Molecular and Cellular Biology, 2005, 25, 3492-3505
2.5277Citations (PDF)
166Once‐Daily versus Twice‐Daily Lopinavir/Ritonavir in Antiretroviral‐Naive HIV‐Positive Patients: A 48‐Week Randomized Clinical Trial
Journal of Infectious Diseases, 2004, 189, 265-272
3.8114Citations (PDF)
167Genomic Analysis of the Nuclear Receptor Family: New Insights Into Structure, Regulation, and Evolution From the Rat Genome
Genome Research, 2004, 14, 580-590
4.6194Citations (PDF)
168Genome sequence of the Brown Norway rat yields insights into mammalian evolution
Nature, 2004, 428, 493-521
38.72,026Citations (PDF)
169Selecting the Right Protein‐Scoring Matrix3.314Citations (PDF)
170Title is missing!
Genome Biology, 2002, 3, research0079.1
12.8326Citations (PDF)
171The Breast Cancer Gene Database: a collaborative information resource
Oncogene, 2000, 18, 7958-7965
6.745Citations (PDF)
172Use of Streaming Video in Preclinical Lectures
Academic Medicine, 2000, 75, 517-518
1.54Citations (PDF)
173Relationship Between Basal Body Temperature and Stage of Disease in Asymptomatic HIV-Infected Men0.21Citations (PDF)
174Management and Outcome of Pneumothoraces in Patients Infected with Human Immunodeficiency Virus
Clinical Infectious Diseases, 1996, 23, 624-627
5.421Citations (PDF)
175Genomic scanning for expressed sequences in Xp21 identifies the glycerol kinase gene
Nature Genetics, 1993, 4, 367-372
26.145Citations (PDF)
176Phylogenetic and Structural Analyses of MMTV LTR ORF Sequences of Exogenous and Endogenous Origins
Virology, 1993, 193, 171-185
2.380Citations (PDF)
177Behavior in Light-Dark Cycles of Drosophila Mutants That Are Arrhythmic, Blind, or Both2.9298Citations (PDF)
178Artificial neural network classification of Drosophila courtship song mutants
Biological Cybernetics, 1992, 66, 485-496
1.511Citations (PDF)
179Behavior of period-altered circadian rhythm mutants ofDrosophila in light: Dark cycles (Diptera: Drosophilidae)
Journal of Insect Behavior, 1992, 5, 417-446
0.8172Citations (PDF)
180Spectral analysis of courtship songs in behavioral mutants ofDrosophila melanogaster
Behavior Genetics, 1989, 19, 503-528
1.559Citations (PDF)
181Spectral analysis ofDrosophila courtship songs:D. melanogaster, D. simulans, and their interspecific hybrid
Behavior Genetics, 1988, 18, 675-703
1.567Citations (PDF)
182Germ-Line Transformation Involving DNA from the<i>period</i>Locus in<i>Drosophila melanogaster</i>: Overlapping Genomic Fragments that Restore Circadian and Ultradian Rhythmicity to<i>per<sup>0</sup></i>and<i>per<sup>−</sup></i>Mutants
Journal of Neurogenetics, 1986, 3, 249-291
1.8180Citations (PDF)
183Humoral factors during South American visceral leishmaniasis1.25Citations (PDF)
184Molecular basis of altered mouse mammary tumor virus expression in the D-2 hyperplastic alveolar nodule line of BALB/c mice
Virology, 1985, 143, 1-15
2.313Citations (PDF)
185Molecular analysis of the period locus in Drosophila melanogaster and identification of a transcript involved in biological rhythms
Cell, 1984, 38, 701-710
34.1408Citations (PDF)
186P-element transformation with period locus DNA restores rhythmicity to mutant, arrhythmic drosophila melanogaster
Cell, 1984, 39, 369-376
34.1383Citations (PDF)
187Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients
OncoImmunology, 0, , e1467856
5.528Citations (PDF)